Acorda Therapeutics Inc. (ACOR)
NASDAQ: ACOR
· Real-Time Price · USD
0.66
-0.21 (-24.14%)
At close: Apr 03, 2024, 3:59 PM
Acorda Therapeutics Ratios and Metrics
Financials in USD. Fiscal
year is
January - December.
Fiscal Year | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
Period Ending | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
PE Ratio | -0.03 | -0.00 | -0.09 | -0.07 | -0.04 | 0.04 | -0.02 | -0.01 | -0.04 | -0.06 | -0.08 | -0.09 | -0.06 |
PEG Ratio | 0.00 | -0.00 | 0.02 | 0.00 | 0.00 | -0.00 | 0.00 | -0.00 | -0.01 | 0.00 | -0.01 | 0.00 | 0.00 |
PS Ratio | 0.14 | 0.06 | 0.11 | 0.09 | 0.11 | 0.10 | 0.04 | 0.04 | 0.16 | 0.13 | 0.27 | 0.25 | 0.27 |
PB Ratio | -0.02 | -0.02 | 0.05 | 0.04 | 0.03 | 0.03 | 0.02 | 0.01 | 0.03 | 0.03 | 0.05 | 0.04 | 0.04 |
P/FCF Ratio | -0.14 | -0.79 | 0.42 | -0.23 | -0.34 | 0.34 | -0.61 | -0.09 | -0.26 | 1.46 | -0.95 | -0.9 | -0.29 |
P/OCF Ratio | -0.14 | -0.8 | 0.41 | -0.23 | -0.34 | 0.34 | -0.66 | -0.09 | -0.26 | 1.46 | -0.95 | -0.91 | -0.29 |
OCF/S Ratio | -0.99 | -0.08 | 0.27 | -0.39 | -0.32 | 0.29 | -0.05 | -0.47 | -0.61 | 0.09 | -0.29 | -0.27 | -0.93 |
Debt / Equity Ratio | -1.05 | -1.21 | 3.16 | 2.67 | 2.30 | 1.85 | 2.56 | 2.18 | 1.52 | 1.26 | 1.15 | 0.98 | 1.23 |
Quick Ratio | 0.15 | 0.26 | 1.21 | 1.65 | 1.57 | 1.83 | 1.34 | 1.49 | 1.43 | 1.55 | 1.12 | 1.28 | 1.22 |
Current Ratio | 0.22 | 0.33 | 1.59 | 2.14 | 1.96 | 2.16 | 1.71 | 1.86 | 1.75 | 1.89 | 1.42 | 1.65 | 1.43 |
Asset Turnover | 0.25 | 0.32 | 0.08 | 0.08 | 0.06 | 0.08 | 0.09 | 0.08 | 0.05 | 0.08 | 0.07 | 0.06 | 0.05 |
Interest Coverage | -2.44 | 0.16 | -0.32 | -0.47 | -1.66 | 0.74 | -1.28 | -2.28 | -2.21 | -1.58 | -3.21 | -2.04 | -3.68 |
Return on Equity | 0.15 | 1.38 | -0.15 | -0.14 | -0.22 | 0.20 | -0.18 | -0.53 | -0.19 | -0.14 | -0.16 | -0.12 | -0.16 |
Return on Assets | -0.34 | -1.85 | -0.02 | -0.03 | -0.04 | 0.05 | -0.04 | -0.11 | -0.06 | -0.05 | -0.06 | -0.05 | -0.06 |
Return on Invested Capital | -0.39 | 0.02 | -0.01 | -0.01 | -0.03 | 0.01 | -0.03 | -0.11 | -0.04 | -0.03 | -0.05 | -0.04 | -0.05 |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | 0.82 | 0.65 | 0.88 | 0.90 | 0.85 | 0.86 | 0.67 | 0.72 | 0.74 | 0.89 | 0.58 | 0.64 | 0.59 |
Net Profit Margin | -1.35 | -5.73 | -0.32 | -0.32 | -0.76 | 0.61 | -0.41 | -1.5 | -1.09 | -0.56 | -0.86 | -0.72 | -1.16 |
Pretax Profit Margin | -1.34 | -6.74 | -0.36 | -0.38 | -0.85 | 0.69 | -0.37 | -0.65 | -1.08 | -0.51 | -0.96 | -0.74 | -1.27 |
Operating Profit Margin | -0.97 | 0.04 | -0.09 | -0.12 | -0.56 | 0.14 | -0.29 | -0.55 | -0.74 | -0.31 | -0.73 | -0.49 | -1 |
FCF Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
EBITDA Margin | -0.62 | 0.25 | 0.01 | 0.11 | -0.2 | 0.38 | -0.19 | -0.4 | -0.5 | 0.26 | -0.37 | -0.65 | -0.78 |